| Synthesis of new conjugated coumarin–benzimidazole hybrids and their anticancer activity K Paul, S Bindal, V Luxami Bioorganic & medicinal chemistry letters 23 (12), 3667-3672, 2013 | 158 | 2013 |
| Triazine as a promising scaffold for its versatile biological behavior P Singla, V Luxami, K Paul European journal of medicinal chemistry 102, 39-57, 2015 | 137 | 2015 |
| Synthesis of pyrazole-based hybrid molecules: search for potent multidrug resistance modulators P Singh, K Paul, W Holzer Bioorganic & medicinal chemistry 14 (14), 5061-5071, 2006 | 119 | 2006 |
| Benzimidazole-biologically attractive scaffold for protein kinase inhibitors P Singla, V Luxami, K Paul RSC Advances 4 (24), 12422-12440, 2014 | 114 | 2014 |
| Insights of 8-hydroxyquinolines: A novel target in medicinal chemistry R Gupta, V Luxami, K Paul Bioorganic chemistry 108, 104633, 2021 | 98 | 2021 |
| Imidazo [1, 2-a] pyridines: Promising drug candidate for antitumor therapy R Goel, V Luxami, K Paul Current Topics in Medicinal Chemistry 16 (30), 3590-3616, 2016 | 97 | 2016 |
| Triazine–benzimidazole hybrids: Anticancer activity, DNA interaction and dihydrofolate reductase inhibitors P Singla, V Luxami, K Paul Bioorganic & medicinal chemistry 23 (8), 1691-1700, 2015 | 94 | 2015 |
| 1, 8‐Naphthalimide: a potent DNA intercalator and target for cancer therapy R Tandon, V Luxami, H Kaur, N Tandon, K Paul The Chemical Record 17 (10), 956-993, 2017 | 89 | 2017 |
| Synthesis and in vitro antitumor evaluation of primary amine substituted quinazoline linked benzimidazole K Paul, A Sharma, V Luxami Bioorganic & Medicinal Chemistry Letters 24 (2), 624-629, 2014 | 83 | 2014 |
| Traceless directing groups: a novel strategy in regiodivergent C–H functionalization G Rani, V Luxami, K Paul Chemical Communications 56 (83), 12479-12521, 2020 | 78 | 2020 |
| A fluorescent probe with “AIE+ ESIPT” characteristics for Cu2+ and F− ions estimation AS Gupta, K Paul, V Luxami Sensors and Actuators B: Chemical 246, 653-661, 2017 | 76 | 2017 |
| Synthesis and in vitro evaluation of novel triazine analogues as anticancer agents and their interaction studies with bovine serum albumin P Singla, V Luxami, K Paul European Journal of Medicinal Chemistry 117, 59-69, 2016 | 73 | 2016 |
| Recent advances in development of imidazo [1, 2-a] pyrazines: synthesis, reactivity and their biological applications R Goel, V Luxami, K Paul Organic & biomolecular chemistry 13 (12), 3525-3555, 2015 | 71 | 2015 |
| Synthesis, single crystal and antitumor activities of benzimidazole–quinazoline hybrids A Sharma, V Luxami, K Paul Bioorganic & medicinal chemistry letters 23 (11), 3288-3294, 2013 | 64 | 2013 |
| Novel pyrazolo [3, 4-d] pyrimidine with 4-(1H-benzimidazol-2-yl)-phenylamine as broad spectrum anticancer agents: Synthesis, cell based assay, topoisomerase inhibition, DNA … P Singla, V Luxami, R Singh, V Tandon, K Paul European journal of medicinal chemistry 126, 24-35, 2017 | 63 | 2017 |
| FRET-based ratiometric detection of Hg 2+ and biothiols using naphthalimide–rhodamine dyads V Luxami, M Verma, R Rani, K Paul, S Kumar Organic & Biomolecular Chemistry 10 (40), 8076-8081, 2012 | 55 | 2012 |
| Aggregation induced emission-excited state intramolecular proton transfer based “off-on” fluorescent sensor for Al3+ ions in liquid and solid state G Kumar, K Paul, V Luxami Sensors and Actuators B: Chemical 263, 585-593, 2018 | 49 | 2018 |
| Recent Advances and Developments of in vitro Evaluation of Heterocyclic Moieties on Cancer Cell Lines R Tandon, I Singh, V Luxami, N Tandon, K Paul The Chemical Record 19 (2-3), 362-393, 2019 | 46 | 2019 |
| Synthetic approaches and functionalizations of imidazo [1, 2-a] pyrimidines: an overview of the decade R Goel, V Luxami, K Paul RSC advances 5 (99), 81608-81637, 2015 | 44 | 2015 |
| Synthesis, in vitro evaluation and molecular modelling of naphthalimide analogue as anticancer agents M Verma, V Luxami, K Paul European Journal of Medicinal Chemistry 68, 352-360, 2013 | 44 | 2013 |
